Filing Details

Accession Number:
0001209191-20-048205
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-25 15:56:56
Reporting Period:
2020-08-21
Accepted Time:
2020-08-25 15:56:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1515673 Ultragenyx Pharmaceutical Inc. RARE Pharmaceutical Preparations (2834) 272546083
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1598426 William Aliski C/O Ultragenyx Pharmaceutical Inc.
60 Leveroni Court
Novato CA 94949
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-21 5,000 $58.74 62,018 No 4 M Direct
Common Stock Disposition 2020-08-21 5,000 $86.57 57,018 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-08-21 5,000 $0.00 5,000 $58.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2029-06-11 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 70,350 Indirect By trust
Common Stock 9,686 Indirect By trust
Common Stock 10,456 Indirect By trust
Footnotes
  1. These shares are held in a trust for the benefit of the Reporting Person's spouse and children. The Reporting Person's spouse and nephew are trustees of the trust.
  2. These shares are held in a grantor retained annuity trust. The Reporting Person is the trustee of the trusts.
  3. The option vested in full on June 11, 2020, the first anniversary of the grant date.